151 related articles for article (PubMed ID: 16507946)
1. Aneuploidy screening: what test should I use?
Berkowitz RL; Cuckle HS; Wapner R; D'Alton ME
Obstet Gynecol; 2006 Mar; 107(3):715-8. PubMed ID: 16507946
[TBL] [Abstract][Full Text] [Related]
2. Stepwise sequential screening for fetal aneuploidy.
Benn PA; Campbell WA; Zelop CM; Ingardia C; Egan JF
Am J Obstet Gynecol; 2007 Sep; 197(3):312.e1-5. PubMed ID: 17826434
[TBL] [Abstract][Full Text] [Related]
3. First trimester screening.
Ellestad SC; Wells SR; Kuller JA
Gynecol Obstet Invest; 2005; 60(1):58-62. PubMed ID: 15687731
[TBL] [Abstract][Full Text] [Related]
4. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
Saller DN; Canick JA
Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Prenatal Risk Calculation (PRC) with PIA Fetal Database software in first-trimester screening for fetal aneuploidy.
Hörmansdörfer C; Scharf A; Golatta M; Vaske B; Corral A; Hillemanns P; Schmidt P
Ultrasound Obstet Gynecol; 2009 Feb; 33(2):147-51. PubMed ID: 19009535
[TBL] [Abstract][Full Text] [Related]
6. Sequential and contingent prenatal screening for Down syndrome.
Wald NJ; Rudnicka AR; Bestwick JP
Prenat Diagn; 2006 Sep; 26(9):769-77. PubMed ID: 16821246
[TBL] [Abstract][Full Text] [Related]
7. Combining first and second trimester markers for Down syndrome screening: think twice.
Cocciolone R; Brameld K; O'Leary P; Haan E; Muller P; Shand K
Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):492-500. PubMed ID: 19032666
[TBL] [Abstract][Full Text] [Related]
8. Identification of nucleated red blood cells in maternal circulation: a second step in screening for fetal aneuploidies and pregnancy complications.
Mavrou A; Kouvidi E; Antsaklis A; Souka A; Kitsiou Tzeli S; Kolialexi A
Prenat Diagn; 2007 Feb; 27(2):150-3. PubMed ID: 17186566
[TBL] [Abstract][Full Text] [Related]
9. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
10. Integrated, sequential, and contingent screening for Down syndrome - local needs should drive methodology.
Wyatt P
Prenat Diagn; 2007 Feb; 27(2):186-7. PubMed ID: 17266162
[No Abstract] [Full Text] [Related]
11. Health literacy and patient understanding of screening tests for aneuploidy and neural tube defects.
Cho RN; Plunkett BA; Wolf MS; Simon CE; Grobman WA
Prenat Diagn; 2007 May; 27(5):463-7. PubMed ID: 17345585
[TBL] [Abstract][Full Text] [Related]
12. First- and second-trimester evaluation of risk for Down syndrome.
Ball RH; Caughey AB; Malone FD; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Emig D; D'Alton ME;
Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
[TBL] [Abstract][Full Text] [Related]
13. Screening for aneuploidy in twins and higher-order multiples: is first-trimester nuchal translucency the solution?
Odibo AO; Lawrence-Cleary K; Macones GA
Obstet Gynecol Surv; 2003 Sep; 58(9):609-14. PubMed ID: 12972836
[TBL] [Abstract][Full Text] [Related]
14. The use of prenatal ultrasound for the detection of fetal aneuploidy.
Holmgren C; Lacoursiere DY
Clin Obstet Gynecol; 2008 Mar; 51(1):48-61. PubMed ID: 18303499
[TBL] [Abstract][Full Text] [Related]
15. [How to improve the screening and diagnosis of fetal aneuploidy?].
Ville Y
Bull Acad Natl Med; 2005 Nov; 189(8):1773-84; discussion 1784-7. PubMed ID: 16737102
[TBL] [Abstract][Full Text] [Related]
16. Advanced first trimester screening (AFS): an improved test strategy for the individual risk assessment of fetal aneuploidies and malformations.
Schmidt P; Rom J; Maul H; Vaske B; Hillemanns P; Scharf A
Arch Gynecol Obstet; 2007 Aug; 276(2):159-66. PubMed ID: 17342500
[TBL] [Abstract][Full Text] [Related]
17. [Sonographic screening studies in pregnancy].
Schillinger H
Ultraschall Med; 1984 Dec; 5(6):281-6. PubMed ID: 6395333
[TBL] [Abstract][Full Text] [Related]
18. [Three-dimensional scatter plot analysis to estimate the risk of foetal aneuloidy].
Schmidt P; Hörmansdörfer C; Oehler K; Härtel H; Hillemanns P; Scharf A
Z Geburtshilfe Neonatol; 2008 Aug; 212(4):127-35. PubMed ID: 18729035
[TBL] [Abstract][Full Text] [Related]
19. Preliminary analysis of the new 'Prenatal Risk Calculation (PRC)' software.
Hörmansdörfer C; Scharf A; Golatta M; Vaske B; Hillemanns P; Schmidt P
Arch Gynecol Obstet; 2009 Apr; 279(4):511-5. PubMed ID: 18704469
[TBL] [Abstract][Full Text] [Related]
20. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
Brossard P; Boulvain M; Coll O; Barlow P; Aebi-Popp K; Bischof P; Martinez de Tejada B; ;
AIDS; 2008 Oct; 22(15):2013-7. PubMed ID: 18784463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
